InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Yancopoulos George, Président et Directeur Scientifique. Insider active across 1 company, notably Regeneron Pharmaceuticals, INC.. Cumulatively, 16 disclosures have been published. Breakdown: 0 buy · 8 sells. Total volume traded: €64.1m. History available since 12 January 2021. The latest transaction was filed on 31 December 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Yancopoulos George
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
28,570 shares0Common StockSEC:0001226690-26-000002:0
146,815 shares@ US$555.6729.6% of flowCommon StockSEC:0001226690-25-000005:0
75,799 shares0Common StockSEC:0001883850-24-000033:0
111 shares@ US$965.690.0% of flowCommon StockSEC:0001968202-24-000093:0
907 shares@ US$967.400.4% of flowCommon StockSEC:0001968202-24-000094:0
16,848 shares@ US$900.006.0% of flowCommon StockSEC:0001883850-24-000012:0
36,296 shares0Common StockSEC:0001883850-24-000013:0
172,723 shares@ US$399.6628.0% of flowCommon StockSEC:0001968202-24-000068:0
16,848 shares@ US$900.006.0% of flowCommon StockSEC:0001883850-24-000007:0
25,155 sharesCommon StockSEC:0001883850-23-000095:0
254 shares@ US$800.590.1% of flowCommon StockSEC:0001883850-23-000062:0
13,189 shares@ US$800.084.3% of flowCommon StockSEC:0001883850-23-000044:0
239,063 shares@ US$179.1317.0% of flowCommon StockSEC:0001883850-21-000034:0
773 shares@ US$625.000.2% of flowCommon StockSEC:0001708138-21-000055:0
50,000 shares@ US$600.0611.4% of flowCommon StockSEC:0001708138-21-000044:0
82,108 shares0Common StockSEC:0001708138-21-000026:0
16 of 16 declarations
About Yancopoulos George
YANCOPOULOS GEORGE is Président et Directeur Scientifique, with a stated role of Bd. Co-Chair, President & CSO at Regeneron Pharmaceuticals, INC. He has 16 filings in total, and across the sampled recent filings the dominant transaction nature is Cession, with 0 in buys and 64105622 in sells, over the period from 2021-06-23 to 2026-01-05.
